索引超出了数组界限。
[1] 杨铠瑞, 孙煌, 柴圣杰, 等. 二尖瓣反流诊断策略及手术治疗进展[J]. 国际心血管病杂志, 2023, 50(1):13-16.
[2] Stolz L, Doldi PM, Orban M, et al. Staging heart failure patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair[J]. JACC Cardiovasc Interv, 2023, 16(2):140-151.
[3] Khatib D, Neuburger PJ, Pan S, et al. Transcatheter mitral valve interventions for mitral regurgitation: a review of mitral annuloplasty, valve replacement, and chordal repair devices[J]. J Cardiothorac Vasc Anesth, 2022, 36(10):3887-3903.
[4] Qu G, Peng YG. Substantial challenge for a patient with severe mitral regurgitation and pulmonary hypertension undergoing transcatheter mitral valve edge-to-edge repair procedure[J]. J Anesth Transl Med, 2024, 3(2):45-49.
[5] 徐亚鹏, 王海山, 杨夏燕, 等. 经导管二尖瓣置换产品设计开发及临床研究进展[J]. 中国介入心脏病学杂志, 2022, 30(10):791-796.
[6] Wang XQ, Fan XD, Ma YP, et al. Transcatheter mitral valve repair versus transcatheter mitral valve replacement in patients with mitral insufficiency[J]. Arch Med Res, 2023, 54(2):145-151.
[7] Alperi A, Granada JF, Bernier M, et al. Current status and future prospects of transcatheter mitral valve replacement: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 77(24):3058-3078.
[8] Haddad RN, Bonnet D, Alsac JM, et al. Promising PTFE-coating technology of Optimus-CVS? stents: the new player for congenital heart disease interventions[J]. Int J Cardiol Congenit Heart Dis, 2022, 7:100323.
[9] Song MZ, Tang ZJ, Liu YH, et al. Yak pericardium as an alternative biomaterial for transcatheter heart valves[J]. Front Bioeng Biotechnol, 2021, 9:766991.
[10] Bourguignon T, Espitalier F, Pantaleon C, et al. Bioprosthetic mitral valve replacement in patients aged 65 years or younger:long-term outcomes with the Carpentier-Edwards PERIMOUNT pericardial valve[J]. Eur J Cardiothorac Surg, 2018, 54(2):302-309.